Stock Analysis on Net

Thermo Fisher Scientific Inc. (NYSE:TMO)

Balance Sheet: Assets

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

Thermo Fisher Scientific Inc., consolidated balance sheet: assets

US$ in millions

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Cash and cash equivalents 8,077 8,524 4,477 10,325 2,399
Accounts receivable, less allowances 8,221 8,115 7,977 5,741 4,349
Inventories 5,088 5,634 5,051 4,029 3,370
Contract assets, net 1,443 1,312 968 731 603
Other current assets 1,760 1,644 1,640 1,131 1,172
Current assets 24,589 25,229 20,113 21,957 11,893
Property, plant and equipment, net 9,448 9,280 8,333 5,912 4,749
Acquisition-related intangible assets, net 16,670 17,442 20,113 12,685 14,014
Other assets 3,999 4,007 4,640 2,457 2,011
Goodwill 44,020 41,196 41,924 26,041 25,714
Long-term assets 74,137 71,925 75,010 47,095 46,488
Total assets 98,726 97,154 95,123 69,052 58,381

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).


Assets: Selected Items

Balance sheet item Description The company
Current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Thermo Fisher Scientific Inc. current assets increased from 2021 to 2022 but then slightly decreased from 2022 to 2023.
Property, plant and equipment, net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. Thermo Fisher Scientific Inc. property, plant and equipment, net increased from 2021 to 2022 and from 2022 to 2023.
Long-term assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. Thermo Fisher Scientific Inc. long-term assets decreased from 2021 to 2022 but then increased from 2022 to 2023 not reaching 2021 level.
Total assets Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Thermo Fisher Scientific Inc. total assets increased from 2021 to 2022 and from 2022 to 2023.

Current Assets: Selected Items

Balance sheet item Description The company
Cash and cash equivalents Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Thermo Fisher Scientific Inc. cash and cash equivalents increased from 2021 to 2022 but then slightly decreased from 2022 to 2023.
Accounts receivable, less allowances Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection. Thermo Fisher Scientific Inc. accounts receivable, less allowances increased from 2021 to 2022 and from 2022 to 2023.
Inventories Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. Thermo Fisher Scientific Inc. inventories increased from 2021 to 2022 but then slightly decreased from 2022 to 2023 not reaching 2021 level.